Mallinck­rodt signs re­struc­ture agree­ment with cred­i­tors, plans to file for bank­rupt­cy

Mallinck­rodt plans to file for bank­rupt­cy in the com­ing days for the sec­ond time in three years in a deal that al­lows it to pay $1 bil­lion less to an opi­oid trust than it orig­i­nal­ly agreed to pay.

The drug­mak­er said Wednes­day it struck a deal with the ma­jor­i­ty of its cred­i­tors, in­clud­ing the opi­oid trust. It now plans to make a fi­nal pay­ment of $250 mil­lion to the trust that it’s been pay­ing in­to as part of a $1.7 bil­lion set­tle­ment that re­sult­ed from the com­pa­ny’s role in the US opi­oid epi­dem­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER